COVID-19与非COVID-19急性呼吸窘迫综合征相关脑血管损伤的MRI:配对病例对照研究
该配对病例对照研究比较了COVID-19 ARDS(2020年3月至2021年7月)与非COVID-19 ARDS(2010年1月至2018年10月)患者在索引住院期间脑MRI上的脑血管损伤频率与模式。共26例COVID-19 ARDS和66例非COVID-19 ARDS患者接受脑MRI,形成23对年龄和性别匹配的配对。总体脑血管损伤(57% vs 61%)、脑缺血(35% vs 43%)、颅内出血(43% vs 48%)和脑微出血(52% vs 41%)在两组间相似(所有p值>0.05)。然而,4/26例(15%)COVID-19患者出现播散性白质脑病伴 underlying 脑微出血,而非COVID-19 ARDS患者中无一例出现,该影像模式此前已在COVID-19患者中报道。
要点
- 在因脑MRI检查而入选的ARDS患者中,COVID-19 ARDS与非COVID-19 ARDS的总体脑血管损伤频率相似(57% vs 61%,p>0.05)。
- 脑缺血(35% vs 43%)、颅内出血(43% vs 48%)和脑微出血(52% vs 41%)在COVID-19与非COVID-19 ARDS间均无显著差异(所有p值>0.05)。
- 4/26例(15%)COVID-19 ARDS患者出现播散性白质脑病伴 underlying 脑微出血,而非COVID-19 ARDS患者中无一例出现。
- 该研究为配对病例对照研究,样本量较小(23对匹配),仅纳入接受脑MRI的 selected ARDS患者。
适用人群与场景
- 成人患者(>18岁)COVID-19 ARDS(2020年3月至2021年7月)和非COVID-19 ARDS(2010年1月至2018年10月),且在索引住院期间接受脑MRI检查。
- 研究场所为三级学术医院系统。
研究设计与关键结果
- 研究设计:病例对照研究;26例COVID-19 ARDS和66例非COVID-19 ARDS患者接受脑MRI,形成23对年龄和性别匹配的配对。
- 总体脑血管损伤频率:COVID-19 ARDS 57% vs 非COVID-19 ARDS 61%(p>0.05)。
- 脑缺血频率:COVID-19 ARDS 35% vs 非COVID-19 ARDS 43%(p>0.05)。
- 颅内出血频率:COVID-19 ARDS 43% vs 非COVID-19 ARDS 48%(p>0.05)。
- 脑微出血频率:COVID-19 ARDS 52% vs 非COVID-19 ARDS 41%(p>0.05)。
- 播散性白质脑病伴 underlying 脑微出血:4/26例(15%)COVID-19 ARDS患者 vs 非COVID-19 ARDS患者0例。
证据类型、等级与局限
- 证据类型:病例对照研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 在因脑MRI检查而入选的ARDS患者中,COVID-19与非COVID-19 ARDS的缺血性和出血性脑血管损伤频率相似,提示这些损伤可能并非COVID-19所特有。
- 播散性出血性白质脑病影像模式仅见于COVID-19 ARDS患者,可能有助于识别COVID-19相关脑损伤,但样本量小,需进一步研究。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVES: Cerebrovascular injury associated with COVID-19 has been recognized, but the mechanisms remain uncertain. Acute respiratory distress syndrome (ARDS) is a severe pulmonary injury, which is associated with both ischemic and hemorrhagic stroke. It remains unclear if cerebrovascular injuries associated with severe COVID-19 are unique to COVID-19 or a consequence of severe respiratory disease or its treatment. The frequency and patterns of cerebrovascular injury on brain MRI were compared among patients with COVID-19 ARDS and non-COVID-19 ARDS.
DESIGN: A case-control study.
SETTING: A tertiary academic hospital system.
PATIENTS: Adult patients (>18 yr) with COVID-19 ARDS (March 2020 to July 2021) and non-COVID-19 ARDS (January 2010-October 2018) who underwent brain MRI during their index hospitalization.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Cerebrovascular injury on MRI included cerebral ischemia (ischemic infarct or hypoxic ischemic brain injury) and intracranial hemorrhage (intraparenchymal, subarachnoid, or subdural, and cerebral microbleed [CMB]).Twenty-six patients with COVID-19 ARDS and sixty-six patients with non-COVID ARDS underwent brain MRI during the index hospitalization, resulting in 23 age- and sex-matched pairs. The frequency of overall cerebrovascular injury (57% vs 61%), cerebral ischemia (35% vs 43%), intracranial hemorrhage (43% vs 48%), and CMB (52% vs 41%) between COVID-19 ARDS and non-COVID-19 ARDS patients was similar (all p values >0.05). However, four of 26 patients (15%) with COVID-19 and no patients with non-COVID-19 ARDS had disseminated leukoencephalopathy with underlying CMBs, an imaging pattern that has previously been reported in patients with COVID-19.
CONCLUSIONS: In a case-control study of selected ARDS patients with brain MRI, the frequencies of ischemic and hemorrhagic cerebrovascular injuries were similar between COVID-19 versus non-COVID-19 ARDS patients. However, the MRI pattern of disseminated hemorrhagic leukoencephalopathy was unique to the COVID-19 ARDS patients in this cohort.
参考来源
- Shoskes A, Huang M, Gedansky A, et al. MRI of Cerebrovascular Injury Associated With COVID-19 and Non-COVID-19 Acute Respiratory Distress Syndrome: A Matched Case-Control Study. Crit Care Med. 2022. PMID: 36094464. doi:10.1097/CCM.0000000000005658
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。